We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$408M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
246
Reduced
378
Closed
79
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.82% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
LCI Industries
LCII
$2.04B
| $39.5M | 0.06% |
641,106
-22,504
| -3% | -$1.24M |
2013 Q2
7 quarters
|
|
227
Coherent
COHR
$49.4B
| $39.2M | 0.06% |
2,122,631
-170,691
| -7% | -$2.81M |
2014 Q4
1 quarter
|
|
228
Kosmos Energy
KOS
$1.6B
| $38.9M | 0.06% |
4,918,403
+74,711
| +2% | +$627K |
2013 Q2
7 quarters
|
|
229
First American
FAF
$6.48B
| $38.9M | 0.06% |
1,089,675
-55,961
| -5% | -$1.95M |
2013 Q2
7 quarters
|
|
230
AutoZone
AZO
$49.5B
| $37.6M | 0.06% |
55,163
-4,444
| -7% | -$2.79M |
2014 Q1
4 quarters
|
|
|
MW
231
DELISTED
THE MENS WAREHOUSE INC
MW
| $37.1M | 0.06% |
710,459
+137,883
| +24% | +$6.69M |
2013 Q2
7 quarters
|
|
232
CDW
CDW
$19.3B
| $36.4M | 0.05% |
977,892
-31,111
| -3% | -$1.13M |
2013 Q3
6 quarters
|
|
233
Oshkosh
OSK
$7.95B
| $35.8M | 0.05% |
+733,279
| New | +$33.5M |
2015 Q1
0 quarters
|
|
234
Texas Instruments
TXN
$255B
| $35.5M | 0.05% |
621,049
+95
| +0% | +$5.33K |
2013 Q2
7 quarters
|
|
235
DELISTED
Berry Global Group, Inc.
BERY
| $35.5M | 0.05% |
1,067,320
-978,522
| -48% | -$30.8M |
2013 Q3
6 quarters
|
|
236
Bank of America
BAC
$362B
| $34.2M | 0.05% |
2,219,843
-1,463,240
| -40% | -$23.5M |
2013 Q2
7 quarters
|
|
237
Evertec
EVTC
$1.88B
| $33.7M | 0.05% |
1,543,881
+95,432
| +7% | +$2.02M |
2014 Q2
3 quarters
|
|
|
HUB.B
238
DELISTED
HUBBELL INC CL-B
HUB.B
| $33.6M | 0.05% |
306,955
+25,574
| +9% | +$2.81M |
2013 Q2
7 quarters
|
|
|
PHH
239
DELISTED
PHH Corporation
PHH
| $33M | 0.05% |
1,365,511
-49,669
| -4% | -$1.2M |
2013 Q2
7 quarters
|
|
240
American Eagle Outfitters
AEO
$3.02B
| $32.8M | 0.05% |
1,919,578
-71,056
| -4% | -$1.08M |
2013 Q2
7 quarters
|
|
|
FINL
241
DELISTED
Finish Line
FINL
| $32.7M | 0.05% |
1,335,443
-57,519
| -4% | -$1.38M |
2013 Q2
7 quarters
|
|
242
Universal Corp
UVV
$1.01B
| $31.8M | 0.05% |
674,714
+26,054
| +4% | +$1.15M |
2013 Q2
7 quarters
|
|
|
HTS
243
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $31.5M | 0.05% |
1,732,921
-25,992
| -1% | -$473K |
2013 Q2
7 quarters
|
|
244
The Mosaic Company
MOS
$6.02B
| $31.4M | 0.05% |
+681,720
| New | +$33.3M |
2015 Q1
0 quarters
|
|
245
Abercrombie & Fitch
ANF
$6.45B
| $31M | 0.05% |
1,408,429
-386,144
| -22% | -$9.52M |
2013 Q2
7 quarters
|
|
246
Zebra Technologies
ZBRA
$17.9B
| $31M | 0.05% |
+341,593
| New | +$29.6M |
2015 Q1
0 quarters
|
|
247
PNC Financial Services
PNC
$85.7B
| $30.9M | 0.05% |
331,546
-85,571
| -21% | -$7.73M |
2013 Q2
7 quarters
|
|
248
Chemed
CHE
$6.74B
| $30.9M | 0.05% |
258,760
-6,819
| -3% | -$757K |
2013 Q2
7 quarters
|
|
249
MFA Financial
MFA
$677M
| $29.9M | 0.04% |
951,304
-36,284
| -4% | -$1.15M |
2013 Q2
7 quarters
|
|
250
DELISTED
THORATEC CORPORATION
THOR
| $29.5M | 0.04% |
704,214
-18,418
| -3% | -$703K |
2014 Q1
4 quarters
|
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 246 increased, 378 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.